Skip to main content

PAVmed Inc (PAVM) Stock

PAVmed Inc Stock Details, Movements and Public Alerts

Stock Details

PAVmed Inc (PAVM), a prominent company in the healthcare sector within the medical devices industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $0.34. Over the past 52 weeks, it has ranged between $0.30 and $1.25. This places the current price at 27.2% of its 52-week high and 11.8% above its 52-week low. Recent trading volume was recorded at 561,682. The 14-day Relative Strength Index (RSI) stands at 41.78, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.46 by 26.09%. Similarly, it is below its 200-day moving average of $0.61 by 44.26%. The MACD histogram is 0.00, indicating neutral momentum (MACD Line: 0.01, Signal Line: 0.01).

52-Week Range

$1.25 - $0.30

-72.80% from high · +11.84% from low

Avg Daily Volume

575,712

20-day average

100-day avg: 281,988

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

0.10

Below market average

PEG Ratio

0.00

Potentially undervalued

Price to Book

0.74

EV/EBITDA

0.62

EPS (TTM)

$4.41

Price to Sales

9.09

Beta

1.07

Similar volatility to market

How is PAVM valued relative to its earnings and growth?
PAVmed Inc trades at a P/E ratio of 0.10, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong.0
What is PAVM's risk profile compared to the market?
With a beta of 1.07, PAVmed Inc is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 0.74 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

7145.00%

Operating Margin

-78583.00%

EBITDA

$-26,553,000

Return on Equity

10.70%

Return on Assets

-40.40%

Revenue Growth (YoY)

-99.40%

Earnings Growth (YoY)

0.00%

How profitable and efficient is PAVM's business model?
PAVmed Inc achieves a profit margin of 7145.00%, meaning it retains $7145.00 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of -78583.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 10.70% and ROA at -40.40%, the company achieves moderate returns on invested capital.
What are PAVM's recent growth trends?
PAVmed Inc's revenue declined by 99.40% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against MEDICAL DEVICES industry averages for proper context.

Company Size & Market

Market Cap

$9.3M

Revenue (TTM)

$1.02M

Revenue/Share (TTM)

$0.08

Shares Outstanding

21.93M

Book Value/Share

$0.64

Asset Type

Common Stock

What is PAVM's market capitalization and position?
PAVmed Inc has a market capitalization of $9.3M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 21.93M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL DEVICES industry, it competes with other firms in this sector.
How does PAVM's price compare to its book value?
PAVmed Inc's book value per share is $0.64, while the current stock price is $0.34, resulting in a price-to-book (P/B) ratio of 0.53. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$11.00

3135.29% upside potential

Analyst Recommendations

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for PAVM?
2 analysts cover PAVM with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $11.00 implies 3135.3% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on PAVM?
Current analyst recommendations:1 Strong Buy, 1 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Nov 1, 2025, 02:37 AM

Technical Indicators

RSI (14-day)

41.78

Neutral

50-Day Moving Average

$0.46

-26.09% below MA-50

200-Day Moving Average

$0.61

-44.26% below MA-200

MACD Line

0.01

MACD Signal

0.01

MACD Histogram

N/A

Neutral

What does PAVM's RSI value tell investors?
The RSI (Relative Strength Index) for PAVM is currently 41.78, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret PAVM's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.01 below the signal line at 0.01, with histogram at 0.00. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.46) is below the 200-day MA ($0.61), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Oct 23, 2025, 12:30 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for PAVM and get notified when the price changes.

Stay Ahead of the Market with PAVmed Inc Alerts

Set up price alerts for PAVmed Inc and get notified instantly when the price hits your target. Never miss an important price movement again.